Topical cyclosporine A in the treatment of superior limbic keratoconjunctivitis: A long-term follow-up

Cornea

Volumn 27, Issue 2, 2008, Pages 193-195

  Sahin, Afsun ^a   Bozkurt, Banu ^b   Irkec, Murat ^c  

^a OSMANGAZI UNIVERSITY MEDICAL FACULTY   (Turkey)

^b Hacettepe University School of Medicine ^*

^c HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Dry eye; Superior limbic keratoconjunctivitis; Topical cyclosporine A

Indexed keywords

ARTIFICIAL TEAR; CYCLOSPORIN A; DEXAMETHASONE; FLUOROMETHOLONE; LUBRICATING AGENT; SILVER NITRATE;

ADULT; ARTICLE; BURNING SENSATION; CLINICAL ARTICLE; CONJUNCTIVAL HYPEREMIA; DRUG EFFICACY; EYE IRRITATION; FEMALE; FOLLOW UP; HUMAN; KERATOCONJUNCTIVITIS; KERATOPATHY; PHOTOPHOBIA; PRIORITY JOURNAL; RECURRENT DISEASE; SENSORY DYSFUNCTION; SUPERIOR LIMBIC KERATOCONJUNCTIVITIS;

ADMINISTRATION, TOPICAL; ADULT; CYCLOSPORINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KERATOCONJUNCTIVITIS; LIMBUS CORNEAE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; RECURRENCE; TREATMENT OUTCOME;

EID: 38549094577     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e318033bd25     Document Type: Article

References (35)

1. Theodore FH. Superior limbic keratoconjunctivitis. Ear Nose Throat J. 1963;42:25-28.
2. Nelson JD. Superior limbic keratoconjunctivitis (SLK). Eye. 1989;3:180-189.
3. Cher I. Superior limbic keratoconjunctivitis: multifactorial mechanical pathogenesis. Clin Experiment Ophthalmol. 2000;28:181-184.
4. Theodore FH. Superior limbic keratoconjunctivitis. Arch Ophthalmol. 1983;101:1627-1629.
5. Theodore FH. Further observations on superior limbic keratoconjunctivitis. Trans Am Acad Ophthalmol Otolaryngol. 1967;71:341-351.
6. Matsuda A, Tagawa Y, Matsuda H. TGF-beta 2, tenascin, and integrin beta 1 expression in superior limbic keratoconjunctivitis. Jpn J Ophthalmol. 1999;43:251-256.
7. Wright P. Superior limbic keratoconjunctivitis. Trans Ophthalmol Soc UK. 1972;92:555-560.
8. Confino J, Brown SI. Treatment of superior limbic keratoconjunctivitis with topical cromolyn sodium. Ann Ophthalmol. 1987;19:129-131.
9. Grutzmacher RD, Foster RS, Feiler LS. Lodoxamide tromethamine treatment for superior limbic keratoconjunctivitis. Am J Ophthalmol. 1995;120:400-402.
10. Udell IJ, Guidera AC, Madani-Becker J. Ketotifen fumarate treatment of superior limbic keratoconjunctivitis. Cornea. 2002;21:778-780.
11. Mondino BJ, Zaidman GW, Salamon SW. Use of pressure patching and soft contact lenses in superior limbic keratoconjunctivitis. Arch Ophthalmol. 1982;100:1932-1934.
12. Ohashi Y, Watanabe H, Kinoshita S, et al. Vitamin A eyedrops for superior limbic keratoconjunctivitis. Am J Ophthalmol. 1988;105:523-527.
13. Goto E, Shimmura S, Shimazaki J, et al. Treatment of superior limbic keratoconjunctivitis by application of autologous serum. Cornea. 2001;20:807-810.
14. Kabat AG. Lacrimal punctal occlusion therapy for the treatment of superior limbic keratoconjunctivitis. Optom Vis Sci. 1998;75:714-718.
15. Yang HY, Fujishima H, Toda I, et al. Lacrimal punctal occlusion for the treatment of superior limbic keratoconjunctivitis. Am J Ophthalmol. 1997;124:80-87.
16. Passons GA, Wood TO. Conjunctival resection for superior limbic keratoconjunctivitis. Ophthalmology. 1984;91:966-968.
17. Udell IJ, Kenyon KR, Sawa M, et al. Treatment of superior limbic keratoconjunctivitis by thermocauterization of the superior bulbar conjunctiva. Ophthalmology. 1986;93:162-166.
18. Perry HD, Doshi-Carnevale S, Donnenfeld ED, et al. Topical cyclosporine A 0.5% as a possible new treatment for superior limbic keratoconjunctivitis. Ophthalmology. 2003;110:1578-1581.
19. Calne RY, White DJG, Thiru S, et al. Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet. 1978;2:1323-1327.
20. Nussenblatt RB, Palestine AG. Cyclosporine A: immunology, pharmacology and therapeutic uses. Surv Ophthalmol. 1986;31:159-169.
21. Zhao JC, Jin XY. Immunological analysis and treatment of Mooren's ulcer with cyclosporin A applied topically. Cornea. 1993;12:481-488.
22. Liegner JT, Yee RW, Wild JH. Topical cyclosporine therapy for ulcerative keratitis associated with rheumatoid arthritis. Am J Ophthalmol. 1990;109:610-612.
23. Reinhard T, Sundmacher R. Topical cyclosporin A in Thygeson's superficial punctate keratitis. Graefes Arch Clin Exp Ophthalmol. 1999;237:109-112.
24. Stevenson D, Tauber J, Reis BL. Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study Group. Ophthalmology. 2000;107:967-974.
25. Sall K, Stevenson OD, Mundorf TK, et al. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. Ophthalmology. 2000;107:631-639.
26. Williams DL. A comparative approach to topical cyclosporine therapy. Eye. 1997;11:453-464.
27. Bleik JH, Tabbara KF. Topical cyclosporine in vernal keratoconjunctivitis. Ophthalmology. 1991;98:1679-1684.
28. Mendicute J, Aranzasti C, Eder F, et al. Topical cyclosporine A 2% in the treatment of vernal keratoconjunctivitis. Eye. 1997;11:75-78.
29. Secchi AG, Tognon MS, Leonardi A. Topical use of cyclosporine in the treatment of vernal keratoconjunctivitis. Am J Ophthalmol. 1990;110:641-645.
30. Hingorani M, Moodaley L, Calder VL, et al. A randomized, placebo-controlled trial of topical cyclosporine A in steroid-dependent atopic keratoconjunctivitis. Ophthalmology. 1998;105:1715-1720.
31. Akpek EK, Dart JK, Watson S, et al. A randomized trial of topical cyclosporine 0.05% in topical steroid-resistant atopic keratoconjunctivitis. Ophthalmology. 2004;111:476-482.
32. Holland EJ, Chan CC, Kuwabara T, et al. Immunohistologic findings and results of treatment with cyclosporine in ligneous conjunctivitis. Am J Ophthalmol. 1989;107:160-166.
33. Belin MW, Bouchard CS, Frantz S, et al. Topical cyclosporine in high-risk corneal transplants. Ophthalmology. 1989;96:1144-1150.
34. Matsuda A, Tagawa Y, Matsuda H. Cytokeratin and proliferative cell nuclear antigen expression in superior limbic keratoconjunctivitis. Curr Eye Res. 1996;15:1033-1038.
35. Leonardi A, DeFranchis G, Fregona IA, et al. Effects of cyclosporine A on human conjunctival fibroblasts. Arch Ophthalmol. 2001;119:1512-1517.